ExodusPoint Capital Management, LP - PHATHOM PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
ExodusPoint Capital Management, LP ownership history of PHATHOM PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$176
-99.9%
17,008
+125.7%
0.00%
-50.0%
Q1 2021$283,000
-41.6%
7,534
-59.9%
0.00%
-85.2%
Q1 2020$485,00018,7650.03%
Other shareholders
PHATHOM PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Medicxi Ventures Management (Jersey) Ltd 4,901,358$41,368,0008.59%
Frazier Life Sciences Management, L.P. 5,827,415$49,183,0004.64%
Abingworth LLP 1,435,106$12,112,0003.88%
Penn Mutual Asset Management 86,940$734,0000.99%
683 Capital Management, LLC 1,440,000$12,153,0000.86%
Western Standard LLC 109,055$920,0000.70%
MPM BioImpact LLC 193,326$1,632,0000.45%
Newtyn Management, LLC 255,767$2,159,0000.41%
StepStone Group LP 422,085$3,562,0000.38%
Avidity Partners Management LP 1,919,800$16,203,0000.37%
View complete list of PHATHOM PHARMACEUTICALS INC shareholders